Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Mar 16, 2022 12:01pm
140 Views
Post# 34518620

RE:RE:RE:Patent update

RE:RE:RE:Patent update

Management and Thomvest are doing everything they can to get it delisted. It's an easily telegraphed plan. Thomvest knew the offers on table in 2018 and they pulled off the financial engineering to take over the company in 2019. Now, they are burying anything of perceived value in company such as 4050. 


PLIImfoservice wrote: Just checking to see if this stock is still alive 

 

<< Previous
Bullboard Posts
Next >>